ArticleDiabetes, obesity & metabolism2022

Efficacy and safety outcomes of dulaglutide by baseline HbA1c: A post hoc analysis of the REWIND trial.

Edward Franek et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.